TP53 and melanoma: The expression of p53 isoforms was investigated by IHC using a suite of p53 isoform-specific antibodies (Fig. 1A) in a retrospective melanoma cohort of 71 (57.72%) primary melanoma samples and 52 (42.28%) metastatic melanoma samples.